Decoding the regulatory role of ATP synthase inhibitory factor 1 (ATPIF1) in Wallerian degeneration and peripheral nerve regeneration

Abstract

ATP synthase inhibitory factor 1 (ATPIF1), a key modulator of ATP synthase complex activity, has been implicated in various physiological and pathological processes. While its role is established in conditions such as hypoxia, ischemia-reperfusion injury, apoptosis, and cancer, its involvement remains elusive in peripheral nerve regeneration. Leveraging ATPIF1 knockout transgenicmice, this study reveals that the absence of ATPIF1 impedes neural structural reconstruction, leading to delayed sensory and functional recovery. RNA-sequencing unveils a significant attenuation in immune responses following peripheral nerve injury,which attributes to theCCR2/CCL2 signaling axis and results in decreased macrophage infiltration and activation. Importantly, macrophages, not Schwann cells, are identified as key contributors to the delayed Wallerian degeneration in ATPIF1 knockout mice, and affect the overall outcome of peripheral nerve regeneration. These results shed light on the translational potential of ATPIF1 for improving peripheral nerve regeneration.

Keywords

ATP synthase inhibitory factor 1 / CCR2/CCL2 signaling / macrophage infiltration / peripheral nerve injury / Wallerian degeneration

References

[1] C. A. Taylor, D. Braza, J. B. Rice, T. Dillingham, Am. J. Phys. Med. Rehabil. 2008, 87, 381.

[2] J. Noble, C. A. Munro, V. S. Prasad, R. Midha, J. Trauma 1998, 45, 116.

[3] D. Grinsell, C. P. Keating, Biomed Res. Int. 2014, 2014, 698256.

[4] D. P. Kuffler, Prog. Neurobiol. 2014, 116, 1.

[5] a)J. Scheib, A. Höke, Nat. Rev. Neurol. 2013, 9, 668;b)Z. Yan, Y. Qian, C. Fan, Regen. Med. 2021, 16, 683;c)Z. Yan, C. Chen, G. Rosso, Y. Qian, C. Fan, Front. Bioeng. Biotechnol. 2021, 9, 746074.

[6] K. Zhang, M. Jiang, Y. Fang, Annu. Rev. Genet. 2021, 55, 93.

[7] P. Chen, X. Piao, P. Bonaldo, Acta Neuropathol. 2015, 130, 605.

[8] R. Kobayashi, H. Ueno, K. I. Okazaki, H. Noji, Nat. Commun. 2023, 14, 1682.

[9] a)B. Zhou, A. Caudal, X. Tang, J. D. Chavez, T. S. McMillen, A. Keller, O. Villet, M. Zhao, Y. Liu, J. Ritterhoff, P. Wang, S. C. Kolwicz Jr., W. Wang, J. E. Bruce, R. Tian, J. Clin. Investig. 2022, 132, e155333; b)R. Martín-Jiménez, D. Faccenda, E. Allen, H. B. Reichel, L. Arcos, C. Ferraina, D. Strobbe, C. Russell, M. Campanella, Cell Death Dis. 2018, 9, 669;c)L. Formentini, M. Sánchez-Aragó, L. Sánchez-Cenizo, J. M. Cuezva, Mol. Cell 2012, 45, 731;d)L. García-Ledo, C. Nuevo-Tapioles, C. Cuevas-Martín, I. Martínez-Reyes, B. Soldevilla, L. González-Llorente, J. M. Cuezva, Front. Oncol. 2017, 7, 69.

[10] S. Rotshenker, J. Neuroinflammation 2011, 8, 109.

[11] M. P. Coleman, A. Höke, Nat. Rev. Neurosci. 2020, 21, 183.

[12] L. Conforti, J. Gilley, M. P. Coleman, Nat. Rev. Neurosci. 2014, 15, 394.

[13] R. E. Zigmond, F. D. Echevarria, Prog. Neurobiol. 2019, 173, 102.

[14] M. K. Jha, J. V. Passero, A. Rawat, X. H. Ament, F. Yang, S. Vidensky, S. L. Collins, M. R. Horton, A. Hoke, G. A. Rutter, A. Latremoliere, J. D. Rothstein, B. M. Morrison, J. Clin. Investig. 2021, 131, e141964.

[15] a)Y. Qian, Y. Cheng, Y. Ouyang, W.-E. Yuan, C. Fan, NPG Asia Mater. 2019, 11, 36; b)E. Ydens, L. Amann, B. Asselbergh, C. L. Scott, L. Martens, D. Sichien, O. Mossad, T. Blank, S. De Prijck, D. Low, T. Masuda, Y. Saeys, V. Timmerman, R. Stumm, F. Ginhoux, M. Prinz, S. Janssens, M. Guilliams, Nat. Neurosci. 2020, 23, 676.

[16] E. Gore, T. Duparc, A. Genoux, B. Perret, S. Najib, L. O. Martinez, Antioxid. Redox Signal. 2022, 37, 370.

[17] G. A. Wyant, W. Yu, I. P. Doulamis, R. S. Nomoto, M. Y. Saeed, T. Duignan, J. D. McCully, W. G. Kaelin Jr., Science 2022, 377, 621.

[18] S. Domínguez-Zorita, I. Romero-Carramiñana, J. M. Cuezva, P. B. Esparza-Moltó, Front. Physiol. 2022, 13, 868820.

[19] J. W. Wu, H. Hu, J. S. Hua, L. K. Ma, Int. J. Biol. Sci. 2022, 18, 731.

[20] L. Sánchez-Cenizo, L. Formentini, M. Aldea, A. D. Ortega, P. García-Huerta, M. Sánchez-Aragó, J. M. Cuezva, J. Biol. Chem. 2010, 285, 25308.

[21] I. Matic, S. Cocco, C. Ferraina, R. Martin-Jimenez, F. Florenzano, J. Crosby, R. Lupi, G. Amadoro, C. Russell, G. Pignataro, L. Annunziato, A. Y. Abramov, M. Campanella, Pharmacol. Res. 2016, 103, 56.

[22] I. Chung, H. A. Park, J. Kang, H. Kim, S. M. Hah, J. Lee, H. S. Kim, W. S. Choi, J. H. Chung, M. J. Shin, Sci. Rep. 2022, 12, 3874.

[23] J. Raffin, Y. Rolland, A. Genoux, G. Combes, M. Croyal, B. Perret, S. Guyonnet, B. Vellas, L. O. Martinez, P. de Souto Barreto, Int. J. Sport Health Sci. (2023),

[24] L. Fei, X. Ren, H. Yu, Y. Zhan, Front. Immunol. 2021, 12, 771210.

[25] M. A. Dansereau, É. Midavaine, V. Bégin-Lavallée, M. Belkouch, N. Beaudet, J. M. Longpré, S. Mélik-Parsadaniantz, P. Sarret, J. Neuroinflammation 2021, 18, 79.

[26] Y. Wang, J. Zhang, X. Cao, Y. Guan, S. Shen, G. Zhong, X. Xiong, Y. Xu, X. Zhang, H. Wang, J. Ye, Acta Pharm. Sin. B 2021, 11, 1568.

[27] A. R. Bauder, T. A. Ferguson, J. Vis. Exp. 2012, 22, 3606.

[28] J. Lam, P. Katti, M. Biete, M. Mungai, S. AshShareef, K. Neikirk, E. Garza Lopez, Z. Vue, T. A. Christensen, H. K. Beasley, T. A. Rodman, S. A. Murray, J. L. Salisbury, B. Glancy, J. Shao, R. O. Pereira, E. D. Abel, A. Hinton Jr., Cells 2021, 10, 2177.

[29] C. H. Ma, T. Omura, E. J. Cobos, A. Latrémolière, N. Ghasemlou, G. J. Brenner, E. van Veen, L. Barrett, T. Sawada, F. Gao, G. Coppola, F. Gertler, M. Costigan, D. Geschwind, C. J. Woolf, J. Clin. Investig. 2011, 121, 4332.

[30] A. Bozkurt, J. Scheffel, G. A. Brook, E. A. Joosten, C. V. Suschek, D. M. O’Dey, N. Pallua, R. Deumens, Behav. Brain Res. 2011, 219, 55.

[31] Z. Yan, T. Ye, L. Yang, H. Jiang, C. Chen, S. Chen, Y. Qian, C. Fan, Adv. Funct. Mater. 2023, 33, 2211709.

RIGHTS & PERMISSIONS

2024 The Author(s). Exploration published by Henan University and John Wiley & Sons Australia, Ltd.